We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

5 hedge funds and large institutions have $494K invested in Sage Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 185 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

77.93% less ownership

Funds ownership: 78.02% → 0.09% (-78%)

97% less funds holding

Funds holding: 191 → 5 (-186)

100% less capital invested

Capital invested by funds: $446M → $494K (-$445M)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 185

Holders
5
Holders Change
-186
Holders Change %
-97.38%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
185
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$150K
2
IA
IFP Advisors
Florida
+$45

Top Sellers

Rank Fund Capital Flow
1
MAP
Madison Avenue Partners
New York
-$55.4M
2
BlackRock
BlackRock
New York
-$41.5M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$29.8M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$17.8M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$17.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
51
Cubist Systematic Strategies
Connecticut
– -$1.75M -192,258 Closed
Verition Fund Management
52
Verition Fund Management
Connecticut
– -$1.68M -184,445 Closed
Bank of New York Mellon
53
Bank of New York Mellon
New York
– -$1.67M -183,012 Closed
YCM
54
Yakira Capital Management
Connecticut
– -$1.67M -182,634 Closed
Jane Street
55
Jane Street
New York
– -$1.64M -179,619 Closed
Citadel Advisors
56
Citadel Advisors
Florida
– -$1.63M -178,337 Closed
Ameriprise
57
Ameriprise
Minnesota
– -$1.55M -169,860 Closed
SC
58
Slotnik Capital
Texas
– -$1.52M -166,592 Closed
PA
59
Pinnacle Associates
New York
– -$1.42M -156,004 Closed
GCM
60
Graham Capital Management
Connecticut
– -$1.4M -154,051 Closed
Bank of America
61
Bank of America
North Carolina
– -$1.33M -145,799 Closed
Franklin Resources
62
Franklin Resources
California
– -$1.32M -144,917 Closed
American Century Companies
63
American Century Companies
Missouri
– -$1.29M -141,828 Closed
IC
64
IEQ Capital
California
– -$1.28M -140,831 Closed
Susquehanna International Group
65
Susquehanna International Group
Pennsylvania
– -$1.27M -139,666 Closed
JP Morgan Chase
66
JP Morgan Chase
New York
– -$1.21M -132,912 Closed
BHMP
67
Bardin Hill Management Partners
New York
– -$1.11M -121,519 Closed
Tudor Investment Corp
68
Tudor Investment Corp
Connecticut
– -$988K -108,377 Closed
Barclays
69
Barclays
United Kingdom
– -$909K -99,618 Closed
BCM
70
Bridgeway Capital Management
Texas
– -$866K -95,000 Closed
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
– -$838K -91,864 Closed
UBS Group
72
UBS Group
Switzerland
– -$806K -88,333 Closed
AI
73
AdvisorShares Investments
Maryland
– -$763K -83,642 Closed
TAL
74
TIG Advisors LLC
New York
– -$759K -83,200 Closed
Nomura Holdings
75
Nomura Holdings
Japan
– -$730K -80,000 Closed
1 2
3
4 5

SAGE Hedge Fund Activity: Q3 2025 in Review

5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q3 2025, worth a combined $494K — down 100% from $446M a quarter earlier.

Sellers outnumbered buyers: 185 funds closed out of SAGE and 0 opened new positions — a net loss of 185 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $150K. The largest seller was Madison Avenue Partners, exiting entirely with an estimated $55.4M sold.

  • 5 institutional investors held Sage Therapeutics (SAGE) as of Q3 2025, down from 191 in Q2 2025.
  • Funds reported $494K of Sage Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Sage Therapeutics positions in Q3 2025 and 185 closed out, a net change of -185 holders.
  • The largest Sage Therapeutics buyer in Q3 2025 was XTX Topco, an estimated $150K added.
  • The largest Sage Therapeutics seller in Q3 2025 was Madison Avenue Partners, an estimated $55.4M sold.

Based on aggregated 13F filings for Q3 2025.